[Novel central dopaminergic agents derived from atypical di-substituted 2-aminoindane-4, 7. Synthesis and central pharmacological profile].
Ferrer-Mavárez RE, Urdaneta-Gutierrez NC, Porta-Knabenschuh N, Rodríguez-Villasmil LC, Rosales-Peña CC, Espinoza GA, Angel-Migliore LB, Balza-Jiménez Kdel C, Perdomo-Zavarce LE, Faría-Quintero AR, Dabian-Makarem AS, Zapata-Cárdenas MV, Linero-Arrieta AR, Acurero-Castellano GA, Israel-Stern A, Rosario Garrido M, Suárez-Roca H, Migliore de Angel Bdel C, Lopez-D'Sola SE, Charris-Charris J, Ramírez-Moran MM, Angel-Guío JE.
Ferrer-Mavárez RE, et al. Among authors: suarez roca h.
Invest Clin. 2015 Jun;56(2):137-54.
Invest Clin. 2015.
PMID: 26299055
Spanish.